These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 17003089
1. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas. Samander EH, Arnold A. J Clin Endocrinol Metab; 2006 Dec; 91(12):5019-21. PubMed ID: 17003089 [Abstract] [Full Text] [Related]
2. Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia. Brown SB, Brierley TT, Palanisamy N, Salusky IB, Goodman W, Brandi ML, Drüeke TB, Sarfati E, Ureña P, Chaganti RS, Pike JW, Arnold A. J Clin Endocrinol Metab; 2000 Feb; 85(2):868-72. PubMed ID: 10690903 [Abstract] [Full Text] [Related]
3. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors. Shattuck TM, Costa J, Bernstein M, Jensen RT, Chung DC, Arnold A. J Clin Endocrinol Metab; 2002 Aug; 87(8):3911-4. PubMed ID: 12161532 [Abstract] [Full Text] [Related]
4. Molecular pathogenesis of primary hyperparathyroidism. Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, Wild Y, Saucier K. J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775 [Abstract] [Full Text] [Related]
5. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. Cetani F, Pinchera A, Pardi E, Cianferotti L, Vignali E, Picone A, Miccoli P, Viacava P, Marcocci C. J Bone Miner Res; 1999 Jun; 14(6):878-82. PubMed ID: 10352095 [Abstract] [Full Text] [Related]
6. HRPT2 mutational analysis of typical sporadic parathyroid adenomas. Krebs LJ, Shattuck TM, Arnold A. J Clin Endocrinol Metab; 2005 Sep; 90(9):5015-7. PubMed ID: 15956079 [Abstract] [Full Text] [Related]
7. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. Pardi E, Marcocci C, Borsari S, Saponaro F, Torregrossa L, Tancredi M, Raspini B, Basolo F, Cetani F. J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209 [Abstract] [Full Text] [Related]
13. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas. Varshney S, Bhadada SK, Sachdeva N, Arya AK, Saikia UN, Behera A, Rao SD. J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941 [Abstract] [Full Text] [Related]
14. Expression and somatic mutations of SDHAF2 (SDH5), a novel endocrine tumor suppressor gene in parathyroid tumors of primary hyperparathyroidism. Starker LF, Delgado-Verdugo A, Udelsman R, Björklund P, Carling T. Endocrine; 2010 Dec; 38(3):397-401. PubMed ID: 20972721 [Abstract] [Full Text] [Related]
15. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Tahara H, Smith AP, Gas RD, Cryns VL, Arnold A. Cancer Res; 1996 Feb 01; 56(3):599-605. PubMed ID: 8564978 [Abstract] [Full Text] [Related]
19. Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins. Costa-Guda J, Imanishi Y, Palanisamy N, Kawamata N, Phillip Koeffler H, Chaganti RS, Arnold A. Endocrine; 2013 Oct 01; 44(2):489-95. PubMed ID: 23435613 [Abstract] [Full Text] [Related]